Sinsin Pharmaceutical Co., Ltd

KOSDAQ:A002800 Rapporto sulle azioni

Cap. di mercato: ₩100.6b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Sinsin Pharmaceutical Gestione

Gestione criteri di controllo 0/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Ki Lee Byoung

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEOno data
Proprietà del CEO0.3%
Durata media del managementNessun dato
Durata media del Consiglio di amministrazioneNessun dato

Aggiornamenti recenti sulla gestione

Recent updates

What Sinsin Pharmaceutical Co., Ltd's (KOSDAQ:002800) 40% Share Price Gain Is Not Telling You

Jul 30
What Sinsin Pharmaceutical Co., Ltd's (KOSDAQ:002800) 40% Share Price Gain Is Not Telling You

Sinsin Pharmaceutical's (KOSDAQ:002800) Profits May Not Reveal Underlying Issues

Mar 20
Sinsin Pharmaceutical's (KOSDAQ:002800) Profits May Not Reveal Underlying Issues

What Kind Of Shareholders Hold The Majority In Sinsin Pharmaceutical Co., Ltd's (KOSDAQ:002800) Shares?

Mar 06
What Kind Of Shareholders Hold The Majority In Sinsin Pharmaceutical Co., Ltd's (KOSDAQ:002800) Shares?

Is Sinsin Pharmaceutical (KOSDAQ:002800) A Risky Investment?

Feb 08
Is Sinsin Pharmaceutical (KOSDAQ:002800) A Risky Investment?

If You Had Bought Sinsin Pharmaceutical (KOSDAQ:002800) Stock A Year Ago, You Could Pocket A 24% Gain Today

Jan 18
If You Had Bought Sinsin Pharmaceutical (KOSDAQ:002800) Stock A Year Ago, You Could Pocket A 24% Gain Today

We're Not Counting On Sinsin Pharmaceutical (KOSDAQ:002800) To Sustain Its Statutory Profitability

Dec 25
We're Not Counting On Sinsin Pharmaceutical (KOSDAQ:002800) To Sustain Its Statutory Profitability

What Kind Of Investors Own Most Of Sinsin Pharmaceutical Co., Ltd (KOSDAQ:002800)?

Nov 29
What Kind Of Investors Own Most Of Sinsin Pharmaceutical Co., Ltd (KOSDAQ:002800)?

AMMINISTRATORE DELEGATO

Ki Lee Byoung

no data

Mandato

Ki Lee Byoung is President & CEO of Sinsin Pharmaceutical Co., Ltd.